Documents to download

Many people from EU-27 countries, relying on the EU’s rules regarding free movement, work in the UK’s National Health Service (NHS). The proportion of NHS (excluding primary care) staff from EU-27 countries rose slightly between September 2015 and September 2017, from 4.99 percent to 5.56 percent. In social care, 7 percent of workers were from the EU-27 in 2016/17. Since 2012/13 the proportion of workers from non-EU countries in social care has fallen, and the proportion from EU-27 countries has risen.

It has been argued that when the UK leaves the EU more money will be available for public services, as a result of the UK no longer being required to make contributions to the EU budget. However, others have emphasised the potentially greater impact of Brexit on the UK’s economy.

As a member of the EU, the UK currently participates in arrangements which allow UK citizens living in the EU and EU citizens in the UK, as well as those travelling for short periods, to access healthcare while abroad. The Government and the EU have stated that those exercising these rights before the end of the transition period will continue to be able to do so. The Government has also stated that it would like to negotiate continued access to these arrangements for those travelling after the transition period.

Upon its departure from the EU, the UK will cease to be a full member of the European Medicines Agency (EMA). The Prime Minister has said she would like the UK to become an associate member after its withdrawal from the EU, to ensure UK patients are not disadvantaged in accessing medical products.


Documents to download

Related posts

  • Medicinal and agrochemical products can be granted a Supplementary Protection Certificate, an intellectual property right associated with patents, to provide up to five years of additional rights and protections once their patents have expired. In order to apply for an SPC, a product must receive approval to be sold on the UK market. Under the Northern Ireland/Ireland Protocol, products to be sold in Northern Ireland must obtain approval under EU law, whilst products to be sold in the rest of the UK will obtain approval under UK law. Currently, this marketing authorisation is only given on a UK-wide basis. This regulation amends the market authorisation process to enable authorisations to be granted for the Northern Ireland market only and for the Great Britain market only.

  • The regulation of product safety, and weights and measures, is based on EU law. The European Union (Withdrawal) Act 2018 brings this EU law into UK statute, so that it will continue to have effect after the end of the transition period. Amendments since have made to enable this framework to operate smoothly in the UK, and added provisions such as a UK conformity mark. This article looks at a further statutory instrument that amends retained EU law in the area, particularly in light of the Northern Ireland Protocol.